What is the price target for MCS stock?
9 analysts have analysed MCS and the average price target is 24.48 USD. This implies a price increase of 39.25% is expected in the next year compared to the current price of 17.58.
NYSE:MCS • US5663301068
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MARCUS CORPORATION (MCS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-30 | Wedbush | Maintains | Outperform -> Outperform |
| 2026-03-02 | Barrington Research | Maintains | Outperform -> Outperform |
| 2026-01-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-11-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-06 | Benchmark | Maintains | Buy -> Buy |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-04 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2025-07-18 | Wedbush | Initiate | Outperform |
| 2025-05-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-06 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-15 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-11 | Benchmark | Reiterate | Buy -> Buy |
| 2025-03-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-30 | Benchmark | Reiterate | Buy -> Buy |
| 2024-11-25 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-13 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-04 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-01 | Benchmark | Maintains | Buy -> Buy |
| 2024-10-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-02 | Benchmark | Maintains | Buy -> Buy |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-02 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 729.575M 7.70% | 735.56M 0.82% | 758.458M 3.11% | 804.23M 6.03% | 829.53M 3.15% | 835.57M 0.73% | |
| EBITDA YoY % growth | 102.288M 32.84% | 90.951M -11.08% | 91.874M 1.01% | 113.86M 23.93% | 125.08M 9.85% | 835.57M 568.03% | |
| EBIT YoY % growth | 34.987M 253.40% | 22.993M -34.28% | 21.683M -5.70% | 34.859M 60.77% | 43.239M 24.04% | 50.197M 16.09% | |
| Operating Margin | 4.80% | 3.13% | 2.86% | 4.33% | 5.21% | 6.01% | |
| EPS YoY % growth | 0.30 168.18% | -0.26 -186.67% | 0.40 253.85% | 0.57 41.40% | 0.78 38.09% | 0.91 16.38% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.30 28.81% | 0.59 12.65% | 0.20 4.55% | -0.50 1.97% | 0.40 34.66% | 0.68 15.52% | 0.29 47.46% | -0.51 -1.21% | 0.50 24.81% | 0.60 -11.04% |
| Revenue Q2Q % growth | 214.34M 4.03% | 230.14M 9.51% | 208.74M 7.88% | 155.07M 0.43% | 221.5M 3.34% | 238.13M 3.47% | 214.95M 2.97% | 165.7M 6.85% | 245.63M 10.89% | 233.08M -2.12% |
| EBITDA Q2Q % growth | 34.742M -28.56% | 47.126M -37.11% | 31.085M -60.05% | 2.719M 72.09% | 39.254M 12.99% | 49.701M 5.46% | 34.593M 11.29% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 15.384M 16.65% | 27.805M 22.71% | 10.873M 42.82% | -18.242M 5.16% | 19.482M 26.64% | 31.156M 12.05% | 14.962M 37.61% | N/A | N/A | N/A |
All data in USD
9 analysts have analysed MCS and the average price target is 24.48 USD. This implies a price increase of 39.25% is expected in the next year compared to the current price of 17.58.
MARCUS CORPORATION (MCS) will report earnings on 2026-07-30.
The consensus EPS estimate for the next earnings of MARCUS CORPORATION (MCS) is 0.3 USD and the consensus revenue estimate is 214.34M USD.
The number of analysts covering MARCUS CORPORATION (MCS) is 9.